ConvaTec Group (CTEC.L) Stock Analysis & Winston Score
ConvaTec is a British medical supplies company that makes products for people with long-term health conditions. Its main products include wound dressings, ostomy bags (pouches worn by people who have had bowel surgery), devices that deliver medicine under the skin, and products that manage urinary and bowel issues. It sells mostly to hospitals, clinics, and home care patients across the world. The company earns money by selling these consumable medical supplies, meaning customers need to reorder them regularly, which creates a steady and predictable revenue stream. ConvaTec operates in over 100 countries, with strong sales in North America and Europe, and generates roughly $2 billion in annual revenue. Its moat comes from the sticky nature of its products — patients and clinicians rarely switch brands once trained on a specific device or dressing system. The key growth driver is an aging global population that increases demand for chronic care products, while the main risk is pricing pressure from hospital purchasing groups and competition from larger rivals like Coloplast and Hollister.
Winston Score: 56/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (17/30)
- Growth: Mixed (7/20)
- Cash Flow: Strong (8/10)
- Stability: Good (5/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)



